The aims of this study were to identify prognostic factors in patients who developed recurrent hepatocellular carcinoma (HCC) after repeat hepatectomy and to elucidate the role of multicentric occurrence in the second tumor after a first hepatectomy.
Objective
The aims of this study were to identify prognostic factors in patients who developed recurrent hepatocellular carcinoma (HCC) after repeat hepatectomy and to elucidate the role of multicentric occurrence in the second tumor after a first hepatectomy.
Summary Background Data
A repeat hepatectomy for recurrent HCC has been established as the most effective treatment modality, whenever it is possible. However, the prognostic factors for recurrent HCC after repeat hepatectomy have yet to be clarified.
Methods
Forty-one patients who underwent a curative repeat hepatectomy were retrospectively studied. Patient survival and disease-free survival after recurrence were univariately and multivariately analyzed using 38 clinicopathologic variables. The histologic grade of HCC at repeat hepatectomy was also compared with that at first hepatectomy.
Results
Patient survival after repeat hepatectomy did not differ substantially from that in 312 patients undergoing primary hepatectomy. However, the disease-free survival after repeat hepatectomy was significantly lower than that in patients with only a primary hepatectomy (p < 0.05). Multivariate analysis revealed only portal vein invasion in the first hepatectomy to be an independent and significantly poor prognostic factor. Regarding multicentric occurrence at repeat hepatectomy, only 6 of 40 patients (15%) whose specimens could be evaluated histologically were determined to be Edmondson and Steiner's Grade 1.
Conclusions
The only prognostic factor identified in patients with recurrent HCC after repeat hepatectomy was portal vein invasion in the first hepatectomy. Most second tumors after the first hepatectomy are considered to be caused by metastatic recurrence, not by multicentric occurrence.
Hepatocellular carcinoma (HCC) has a high intrahepatic recurrence rate, but long-term survival is possible when the recurrence is appropriately treated on a timely basis.
A repeat hepatectomy for recurrent HCC is the most effective treatment modality,' 5 whenever it is possible. However, the prognostic factors for recurrent HCC after repeat hepatectomy have yet to be clarified, even though those for primary hepatectomy have been well documented.6'-2 It is important to elucidate the prognostic factors in repeat hepatectomy and to clarify the optimal treatment strategy for recurrent HCC.
The controversy over whether the second tumor is caused by true recurrence or is the result of a multicentric occurrence of HCC remains unresolved.'3 Resected specimens obtained at repeat hepatectomy may provide some insight into this issue.
The aims of this study are to identify the prognostic factors in patients with recurrent HCC after repeat hepatectomy and to elucidate the role of multicentric occurrence in second tumors after a first hepatectomy.
MATERIALS AND METHODS
Forty-one patients who underwent a curative repeat hepatectomy at Kyushu University Hospital between November 1978 and December 1995 were retrospectively studied. The operative procedures consisted of a lobectomy in 2, a segmentectomy in 6, a subsegmentectomy in 2, and other minor resections in 31. No incidence of postoperative hospital death was observed. The operative time ranged from 115 to 500 minutes (mean, 257 minutes). Blood loss ranged from 250 to 9600 mL (mean, 1980 mL). A curative operation was defined as one in which all the tumors were macroscopically resected.
Patient survival and disease-free survival in patients with repeat hepatectomy were compared with those in 312 patients who underwent only a primary hepatectomy at our institution between April 1985 and March 1995. Patient survival and disease-free survival after recurrence was compared using the following cinicopathologic variables ( 
Follow-Up
Patient follow-up after hepatic resection has been described elsewhere.3 Briefly, a monthly measurement of a-fetoprotein and protein induced by vitamin K absencell'5 and monthly bedside ultrasonography were performed. Ultrasonography and dynamic computed tomography were performed every 3 months by radiologists. An angiographic examination was done after admission when recurrence was strongly suspected.
Statistical Analysis
Regarding the survival analysis of the prognostic factors for both patient survival and disease-free survival, the survival was calculated by the product limit method of Kaplan and Meier,16 and the differences in the survival between the groups were then compared using the logrank test.1" The results of a univariate analysis helped us reduce substantially the number of study variables. Only a few significant variables were used in the multivariate analysis using Cox's proportional hazard model.'8 The BMDP P2L program (Los Angeles, CA) was simultaneously used for the multivariate adjustment of all covariates by using a stepwise regression analysis on an IBM System 4381 (Armonk, NY) computer. A p value < 0.05 was considered to be significant.
RESULTS
Survival after repeat hepatectomy did not substantially differ from that of the patients who underwent only a primary hepatectomy (Fig. 1) . However, disease-free survival after repeat hepatectomy was significantly lower than that in the primary hepatectomy patients (p < 0.05; Fig. 2 ).
In the univariate analysis, 3 variables were determined Table 1 ). The multivariate analysis finally revealed only the presence of portal vein invasion at the first hepatectomy to be an independent and significant poor prognostic factor (Table 2) .
Regarding multicentric occurrence at repeat hepatectomy, Figure 3 shows that only 6 patients of 40 Figure 4 shows our treatment strategy for recurrent HCC. For an extrahepatic recurrence, surgical treatment is indicated only when the recurrence is isolated and resectable; otherwise, systemic chemotherapy or radiation is indicated. For an intrahepatic recurrence, repeat hepatectomy is indicated when liver function is preserved (Child's classification A or B) and there are fewer than three recurrent nodules. Lipiodolization29'30 or percutaneous ethanol injection therapy is indicated when liver function is impaired or more than four recurrent nodules are found. Patients whose first HCC demonstrated microscopic portal vein invasion should be closely followed and may need a prophylactic postoperative lipiodolization,31 even if a repeat hepatectomy has already been performed for recurrent HCC.
In conclusion, the only prognostic factor found to be significant in patients with recurrent HCC after repeat hepatectomy was the presence of portal vein invasion in the first hepatectomy. Recurrences of HCC after the first hepatectomy are thus considered to represent metastatic recurrence, not multicentric occurrence. Therefore, for patients with recurrent HCC, a repeat hepatectomy is indicated. Surgical indications should be carefully determined for patients in whom the presence of portal vein invasion was histologically recognized at the first hepatectomy.
